Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. AmerisourceBergen Corporation
  6. Summary
    ABC   US03073E1055

AMERISOURCEBERGEN CORPORATION

(ABC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/14/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
136.2(c) 133.81(c) 132.39(c) 132.88(c) 131.52(c) Last
926 949 888 367 894 114 635 660 674 616 Volume
+0.97% -1.75% -1.06% +0.37% -1.02% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 237 B - -
Net income 2022 2 072 M - -
Net Debt 2022 2 015 M - -
P/E ratio 2022 13,5x
Yield 2022 1,41%
Sales 2023 250 B - -
Net income 2023 2 367 M - -
Net cash position 2023 69,2 M - -
P/E ratio 2023 12,1x
Yield 2023 1,48%
Capitalization 27 374 M 27 374 M -
EV / Sales 2022 0,12x
EV / Sales 2023 0,11x
Nbr of Employees 40 000
Free-Float 51,2%
More Financials
Company
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution Services and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. Its Pharmaceutical Distribution Services Segment serves healthcare providers in the pharmaceutical supply channel, the Pharmaceutical... 
Read more
More about the company
Ratings of AmerisourceBergen Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about AMERISOURCEBERGEN CORPORATION
01/13INSIDER SELL : AmerisourceBergen
MT
01/11Barclays Adjusts AmerisourceBergen Price Target to $152 From $135, Maintains Equalweigh..
MT
01/07Georgia Enters $26 Billion Multi-State Opioid Litigation Settlement With Johnson & John..
MT
01/04Nevada to join $26 bln opioid settlement with drug distributors, J&J
RE
01/04Nevada says it agrees to join nationwide $26 billion opioid settlement with johnson & j..
RE
01/04AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Releas..
BU
2021Drugmaker Teva fueled opioid addiction in New York, jury finds
RE
2021Drugmaker Endo strikes $63 million opioid settlement with Texas
RE
2021Health Care Stocks Rising This Afternoon
MT
2021Merck & Co. to Start Shipping Molnupiravir COVID-19 Pill 'Within Days'
MT
2021Merck to Start Shipping Molnupiravir COVID-19 Pill 'Within Days'
MT
2021Merck Expects to Begin Shipping Covid Pill Molnupiravir to AmeriSourceBergen Within Day..
MT
2021McKesson - Distributors Announce Extension of Opioid Settlement Sign-On Period, Partici..
AQ
2021U.S. drug distributors extend deadline for state subdivisions to join opioid settlement
RE
2021Oregon, among last holdout states, to join opioid agreement
AQ
More news
News in other languages on AMERISOURCEBERGEN CORPORATION
01/13VENTE PAR DES INITIÉS : AmerisourceBergen
01/07La Géorgie conclut un accord de 26 milliards de dollars avec Johnson & Johnson et les d..
01/06Corona-Impfungen treiben Walgreens Boots Alliance an - Prognose angehoben
2021Les actions du secteur de la santé en hausse cet après-midi
2021Merck & Co. va commencer à livrer la pilule COVID-19 à base de molnupiravir "d'ici quel..
More news
Analyst Recommendations on AMERISOURCEBERGEN CORPORATION
More recommendations
Analysis
Nevada to join $26 bln opioid settlement with drug distributors, J&J
Chart AMERISOURCEBERGEN CORPORATION
Duration : Period :
AmerisourceBergen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMERISOURCEBERGEN CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 131,52 $
Average target price 148,92 $
Spread / Average Target 13,2%
EPS Revisions
Managers and Directors
Steven H. Collis Senior Vice President
Robert P. Mauch Group President & Executive Vice President
James Francis Cleary Chief Financial Officer & Executive Vice President
Kathy Habecker Gaddes Chief Compliance Officer & Executive VP
Gina K. Clark Chief Communications & Administration Officer, EVP
Sector and Competitors
1st jan.Capi. (M$)
AMERISOURCEBERGEN CORPORATION-1.03%27 374
ABBOTT LABORATORIES-10.59%215 794
MEDTRONIC PLC2.57%141 985
BECTON, DICKINSON AND COMPANY5.23%75 431
HOYA CORPORATION-11.34%49 186
BAXTER INTERNATIONAL INC.0.51%43 200